← All Quidelortho CORP filings

Quidelortho CORP 8-K filings

NASDAQ
QDEL
Quidelortho CORP
8-K: QuidelOrtho Reports Mixed Q4 and Full-Year 2023 Results, Cites Strong Non-Respiratory Growth
QuidelOrtho's fourth quarter and full-year 2023 results show a significant decline in respiratory revenue offset by growth in non-respiratory business and strategic investments.